| Recruiting | Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention NCT06281834 | Brigham and Women's Hospital | Phase 1 |
| Enrolling By Invitation | Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in Uganda NCT06751706 | Queen Mary University of London | — |
| Recruiting | Lung Innate Immunity and Microbiome After Tuberculosis Exposure NCT06526689 | University of Oxford | — |
| Completed | Evaluating the Accuracy of New Tests for TB Infection Diagnosis NCT06221735 | Freundeskreis Für Internationale Tuberkulosehilfe e.V | N/A |
| Unknown | Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease NCT05021731 | Miguel Santín | Phase 4 |
| Recruiting | TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts NCT06022146 | Huashan Hospital | Phase 3 |
| Completed | Clinical Practice Guidelines Versus Decision-support for Latent Tuberculosis Infection (LTBI) Management NCT05772065 | Johns Hopkins University | N/A |
| Active Not Recruiting | One-month Latent Tuberculosis Treatment for Renal Transplant Candidates NCT05411744 | Rutgers, The State University of New Jersey | Phase 4 |
| Active Not Recruiting | Brief Educational Video for Patients Prescribed LTBI Treatment NCT05412212 | Kaiser Permanente | N/A |
| Recruiting | Economic Incentives and vDOT for Latent Tuberculosis Infection NCT05022862 | Johns Hopkins University | N/A |
| Recruiting | New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis NCT05621343 | Region Skane | — |
| Recruiting | Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students NCT05756582 | Eleonora Nucera | — |
| Recruiting | Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis NCT05073926 | Region Skane | — |
| Completed | Implementation of an Integrated Care Strategy for Children Contacts of Patients With Tuberculosis NCT04331262 | Corporacion para Investigaciones Biologicas | — |
| Unknown | Comorbidities and Coinfections in Latent TB NCT04642755 | Tuberculosis Research Centre, India | — |
| Completed | Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation NCT04830462 | Herlev and Gentofte Hospital | Phase 4 |
| Terminated | Microneedles for Diagnosis of LTBI NCT04552015 | The HIV Netherlands Australia Thailand Research Collaboration | N/A |
| Active Not Recruiting | TB Screening Improves Preventive Therapy Uptake NCT04557176 | University of California, San Francisco | N/A |
| Withdrawn | BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population NCT05541952 | Federal University of Mato Grosso | Phase 4 |
| Completed | Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial) NCT03934931 | University of California, San Francisco | N/A |
| Unknown | Prevalence of Latent Tuberculosis in High Risk Children NCT03910946 | Assiut University | — |
| Completed | GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment NCT04528823 | McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| Completed | Tuberculosis Clinical Trials Consortium Study 35 NCT03730181 | Centers for Disease Control and Prevention | Phase 1 / Phase 2 |
| Completed | Improving Rhode Island's Tuberculosis Preventive Services in Primary Care NCT04188041 | Kent Hospital, Rhode Island | N/A |
| Completed | 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB. NCT03988933 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 |
| Recruiting | Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI NCT03474029 | Centers for Disease Control and Prevention | Phase 2 / Phase 3 |
| Completed | Screening for Tuberculosis in Pregnancy NCT04098341 | Queen Mary University of London | N/A |
| Withdrawn | Video Based Directly Observed Therapy for Latent TB NCT03783728 | St. Louis University | — |
| Completed | Doravirine, Rifapentine and Isoniazid Interaction NCT03886701 | Walter K. Kraft | Phase 1 |
| Unknown | Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB) NCT05280886 | Inje University | — |
| Unknown | Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT NCT03220464 | Seoul National University Hospital | N/A |
| Completed | Trial of Vitamin D Supplementation in Cape Town Primary Schoolchildren NCT02880982 | Queen Mary University of London | Phase 3 |
| Completed | COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB) NCT06408129 | University Hospital, Montpellier | — |
| Completed | Completion and Acceptability of Treatment Across Primary Care and the commUnity for Latent Tuberculosis NCT03069807 | Queen Mary University of London | N/A |
| Unknown | Latent Tuberculosis Infection in Korean Health Care Workers NCT03010111 | Hanyang University | N/A |
| Unknown | Improving the Detection of Active Tuberculosis in Accident and Emergency Departments NCT02512484 | Public Health England | — |
| Completed | Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging NCT02690818 | University of Arizona | N/A |
| Completed | Vitamin D Supplementation in TB Prevention NCT02276755 | Harvard School of Public Health (HSPH) | Phase 3 |
| Completed | Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts NCT02454738 | Seoul National University Hospital | N/A |
| Completed | Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa NCT02119130 | Johns Hopkins University | N/A |
| Completed | Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen NCT02090374 | Imperial College London | N/A |
| Completed | Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli NCT02073669 | Sheba Medical Center | N/A |
| Completed | A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456) NCT01865487 | Aeras | Phase 1 / Phase 2 |
| Unknown | Testing for Tuberculosis in the United Kingdom HIV Infected Population NCT02712671 | University College, London | — |
| Completed | Effect of Filarial Infection on Immune Responses in Latent Tuberculosis NCT01547884 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Withdrawn | Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis NCT03498534 | Instituto Nacional de Salud Publica, Mexico | Phase 4 |
| Terminated | Determining Risk in Latent Tuberculosis NCT01571739 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis NCT01967134 | Aeras | Phase 1 |
| Recruiting | Training Protocol on the Natural History of Tuberculosis NCT01212003 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, NCT01162265 | Public Health England | — |
| Completed | Improving Latent Tuberculosis (TB) Diagnosis in Thai Children NCT00947609 | SEARCH Research Foundation | — |
| Completed | Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV? NCT00763295 | Northwell Health | — |
| Completed | Immune Response to Mycobacterium Tuberculosis Infection NCT00257907 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | The Epidemiology of TST Change in Korea NCT01850043 | Asan Medical Center | — |
| Unknown | Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Car NCT00311220 | Taichung Veterans General Hospital | Phase 4 |